Chlorphenamine Dosing for Children
For children 6 to under 12 years of age, administer half a tablet (2 mg) every 4 to 6 hours, not exceeding 3 whole tablets (12 mg) in 24 hours; chlorphenamine is not recommended for children under 6 years of age. 1
Age-Based Dosing Recommendations
Children 6 to Under 12 Years
- Administer 2 mg (half tablet) every 4 to 6 hours 1
- Maximum daily dose: 12 mg (3 whole tablets) in 24 hours 1
- This weight-based dosing achieves therapeutic serum concentrations of 2.3 to 12.1 ng/mL, which effectively suppresses allergic rhinitis symptoms 2
Children 12 Years and Older
Children Under 6 Years
- Do not use chlorphenamine in children under 6 years of age 1
- This contraindication is based on FDA labeling and safety concerns in younger children 1
Pharmacokinetic Considerations in Children
- The elimination half-life in children aged 6-16 years averages 13.1 hours (range 7-19 hours), which is shorter than in adults 2
- Peak plasma concentrations occur 2-4 hours after oral administration, with an absorption lag time of approximately 0.7 hours 3, 4
- Therapeutic serum levels range from 2.3 to 12.1 ng/mL for symptom control and 4.1 to 10.0 ng/mL for histamine wheal suppression 2
- Age-based dosing using a 4-fold range achieves similar maximum concentrations and total drug exposure across pediatric age groups 3
Important Safety Considerations
- Sedation is the most common adverse effect and appears more prevalent in younger children (ages 2-5 years) 3
- Monitor for anticholinergic side effects including dry mouth, urinary retention, and paradoxical excitation 5
- The large volume of distribution (7.0 L/kg) indicates significant tissue binding, which contributes to the drug's prolonged duration of action 2
- Avoid combining with other sedating medications due to increased risk of respiratory depression 5
Clinical Pitfalls to Avoid
- Do not exceed the maximum daily dose, as the long half-life (13-21 hours) leads to significant drug accumulation with frequent dosing 2, 4
- Do not use in children under 6 years despite historical use, as current FDA labeling explicitly contraindicates this practice 1
- Ensure adequate hydration and monitor for urinary retention, particularly in children with predisposing conditions 5
- Administer at least 2 hours after meals to optimize absorption, as food may delay peak concentrations 3